Back to calendar
Ultragenyx Pharmaceutical Inc. (RARE) Earnings
RARE reports earnings on Tuesday, November 3, 2026
earnings report
November 3, 2026 · After Market Close
Q3 2026
Est. EPS: $-1.10
Actual EPS: $-0.90
EPS surprise: 26.09%
Company overview
Market Cap$1.6B
PriceUSD 16.10
EPS (TTM)-5.84
52-week high39.89
52-week low12.73
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees1,371